The Immunotec and MyDailyChoice Integration marks one of the biggest moves in the wellness and direct selling industry in recent years. Immunotec, known globally for its science-backed glutathione products, has officially absorbed MyDailyChoice (MDC), a marketing and affiliate-driven powerhouse with more than $600 million in sales and over 1 million members.
This integration is a major sign of transformation in the industry. It blends clinical research with one of the most energized communities in the network marketing world. And because this event is shaping the future of direct selling, it’s essential to explore its meaning, strategy, and long-term impact.
Immunotec already had strong scientific credibility. But it wanted scale, community growth, and new energy. MyDailyChoice provided exactly that.
Here’s why the integration made perfect sense:
Combining Science-Backed Wellness With Social Commerce Power
Immunotec brings research.
MDC brings reach.
Together, they create a hybrid business model that blends:
This is the same evolution seen across modern wellness companies worldwide.
Immunotec is built on decades of scientific development, especially related to glutathione, the body’s master antioxidant. Its flagship products are backed by peer-reviewed research, clinical studies, and a strong medical advisory network.
Key strengths:
MyDailyChoice: A Marketing Innovation Powerhouse
MDC became a global name for:
Its ability to build a strong digital community is one of the major reasons this integration matters.
Founder of MDC, Josh Zwagil, is now officially an ImmunotecPro, marking a strategic leadership evolution for the entire company.
How Zwagil’s Leadership Strengthens Field Operations
Zwagil brings:
This leadership addition signals Immunotec’s shift toward a more modern, entrepreneurial consultant experience.
The ImmunotecPro identity is more than a title; it’s the future foundation of consultant empowerment.
It includes:
This strategy will likely boost retention and consultant satisfaction.
Latin America has become one of the hottest regions for direct selling growth. Immunotec already has a footprint there, but MDC’s expansion history in the region gives Immunotec even more reach.
The U.S. market is another strategic hotspot, where MDC has built a strong community of affiliates.
Merging CRM systems is one of the most critical steps. It affects:
Compensation Plan Harmonization
Both companies must align:
Done right, this will create a powerful earning opportunity for consultants across the globe.
Trend Toward Consolidation
This integration signals that the industry is moving toward:
Rise of Hybrid Product + Influencer Ecosystems
The future of direct selling is clear:
Research-based products + Influencer-style marketing
Community-driven sales + Data-driven strategies
Immunotec and MDC are perfectly positioned to lead this new model.
Why Glutathione Matters for Aging and Immunity
Glutathione supports:
Immunotec’s Clinical Research Foundation
Its research credibility remains the backbone of the entire brand.
And it’s one of the key reasons this integration is so powerful.
Preserving Brand Clarity Across Two Communities
A major challenge is maintaining Immunotec’s science-first identity while aligning with MDC’s energetic marketing culture.
Managing Rapid Growth Without Losing Quality
Rapid expansion can pressure:
Immunotec must balance scale with product integrity.
Herbalife + Nutrition Clubs
Grassroots entrepreneurship boosted Herbalife’s global impact.
Amway + XS Energy
This merger helped Amway connect with younger markets.
Similarly, Immunotec + MDC blends science with modern influence.
The Immunotec and MyDailyChoice Integration represents a turning point in the global direct selling industry. By merging science, community, leadership, and marketing power, Immunotec is setting itself up for explosive global expansion.
This integration signals a new era: one where research-driven companies team up with influencer-based communities to dominate the wellness market.
There are no reviews yet. Be the first one to write one.